Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Current Standard of Care for Patients Diagnosed With Malignant Melanoma of the Head and Neck - Access to Staging and Surgical Treatment

NCT05900102 is registered in ClinicalTrials.gov with Hull University Teaching Hospitals NHS Trust as lead sponsor.

NCT NCT05900102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05900102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Current Standard of Care for Patients Diagnosed With Malignant Melanoma of the Head and Neck - Access to Staging and Surgical Treatment
Lead sponsor
Hull University Teaching Hospitals NHS Trust
Phase
Observational
Overall status
Completed
Start date
October 1, 2024
Completion date
January 1, 2025
Enrollment
86,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, melanoma (skin)